A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants with Heart Failure due to Systemic Left Ventricular Systolic Dysfunction (VALOR),
Role: Investigator,
Merck,
(03/2025 - 03/2026)
Status: Approved
Internal
Low absolute lymphocyte count associated with anti-thymocyte globulin induction may be a predictor of
early cytomegalovirus infection in pediatric heart transplantation,
Role: PI,
LLU Dept. of Pediatrics,
(08/2024)
Status: Approved
Interventions in children post-heart transplant,
Role: PI,
LLU Dept. of Pediatrics,
(06/2024)
Status: Approved
Pediatric heart transplant study group collaborative database,
Role: Investigator,
LLU Dept. of Pediatrics,
(03/2025 - 03/2026)
Status: Approved
Normalization of hemodynamics after pediatric heart transplant,
Role: PI,
LLU Dept. of Pediatrics,
(04/2023)
Status: Approved
Advanced cardiac therapies improving outcomes network to improve the health of pediatric and congenital heart disease patients with heart failure,
Role: Investigator,
LLU Dept. of Pediatrics,
(12/2019)
Status: Approved
Selexipag for pulmonary hypertension in children of all ages,
Role: PI,
LLU Dept. of Pediatrics,
(08/2019)
Status: Approved
Cardiac Graft Failure in Young Adulthood,
Role: PI,
LLU Dept. of Pediatrics,
(10/2024)
Status: Approved
Non-Profit Organization
Integrating Multi-parametric Echocardiography with Computer Assisted Analyses in Detection for Early Allograft Rejection in Pediatric Heart Transplant Recipients: A Pilot Prospective Multicenter Trial,
Role: PI,
Enduring Hearts Foundation,
(06/2020)
Status: Approved